Acute Myocardial Infarction Market
Acute myocardial infarction (AMI) is heart muscle death caused by sudden blockage of a coronary artery. Symptoms include chest pain, shortness of breath, nausea, or sweating. Diagnosis is made with ECG and cardiac markers. Treatment includes antiplatelet and anticoagulant drugs, beta-blockers, statins, nitrates, and reperfusion therapy.
AMI is a leading cause of death in developed countries and is classified as ST-segment elevation MI (STEMI) or non-ST-segment elevation MI (NSTEMI). STEMI requires urgent reperfusion by fibrinolysis, PCI, or CABG, while NSTEMI is treated with PCI or CABG. Unstable angina resembles NSTEMI but without elevated cardiac markers.
Download the full infographic to uncover detailed insights: https://www.delveinsight.com/infographics/acute-myocardial-infarction-ami-market?utm_source=infographics&utm_medium=promotion&utm_campaign=akpr
